June CPI Data Is Here, Will the Fed Cut Rates?
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
9 minutes ago
- Yahoo
Robert Bruce's Strategic Move: LyondellBasell Industries NV Takes Center Stage
Exploring the Latest 13F Filing and Investment Adjustments Robert Bruce (Trades, Portfolio) recently submitted the 13F filing for the second quarter of 2025, providing insights into his investment moves during this period. Robert Bruce (Trades, Portfolio) is the founder of Bruce & Co, the investment firm that serves as the advisor to the Bruce Fund (BRUFX). The Bruce Fund is run by Robert Bruce (Trades, Portfolio) and his son, Robert Jeffrey Bruce. The Fund focuses primarily on common stock investments, though it also invests in high-yield and distressed debt. It may invest in some long-term U.S. government securities if the managers cannot find attractive opportunities elsewhere. The Fund invests mostly in small- and mid-cap stocks, with the occasional large-cap, as well as convertible and distressed bonds. The Bruces tend to hold their stocks for the long-term, generally preferring the securities of distressed companies that are trading at a significant discount but which they believe can make a turnaround. Summary of New Buy Robert Bruce (Trades, Portfolio) added a total of 1 stock, among them: The most significant addition was LyondellBasell Industries NV (NYSE:LYB), with 40,000 shares, accounting for 0.75% of the portfolio and a total value of $2.31 million. Key Position Increases Robert Bruce (Trades, Portfolio) also increased stakes in a total of 2 stocks, among them: The most notable increase was Vicor Corp (NASDAQ:VICR), with an additional 20,000 shares, bringing the total to 90,000 shares. This adjustment represents a significant 28.57% increase in share count, a 0.3% impact on the current portfolio, with a total value of $4,082,400. The second largest increase was The Chemours Co (NYSE:CC), with an additional 50,000 shares, bringing the total to 250,000. This adjustment represents a significant 25% increase in share count, with a total value of $2,862,500. Summary of Sold Out Robert Bruce (Trades, Portfolio) completely exited 2 of the holdings in the second quarter of 2025, as detailed below: Organon & Co (NYSE:OGN): Robert Bruce (Trades, Portfolio) sold all 31,200 shares, resulting in a -0.15% impact on the portfolio. IGM Biosciences Inc (NASDAQ:IGMS): Robert Bruce (Trades, Portfolio) liquidated all 100,000 shares, causing a -0.04% impact on the portfolio. Key Position Reduces Robert Bruce (Trades, Portfolio) also reduced positions in 4 stocks. The most significant changes include: Reduced CMS Energy Corp (NYSE:CMS) by 30,000 shares, resulting in a -13.27% decrease in shares and a -0.73% impact on the portfolio. The stock traded at an average price of $71.31 during the quarter and has returned 6.67% over the past 3 months and 11.79% year-to-date. Reduced Merck & Co Inc (NYSE:MRK) by 10,000 shares, resulting in a -4.93% reduction in shares and a -0.29% impact on the portfolio. The stock traded at an average price of $79.65 during the quarter and has returned 13.43% over the past 3 months and -15.50% year-to-date. Portfolio Overview At the second quarter of 2025, Robert Bruce (Trades, Portfolio)'s portfolio included 40 stocks, with top holdings including 8.21% in Allstate Corp (NYSE:ALL), 7.98% in U-Haul Holding Co (NYSE:UHAL.B), 7.69% in AbbVie Inc (NYSE:ABBV), 7.1% in NextEra Energy Inc (NYSE:NEE), and 6.97% in AerCap Holdings NV (NYSE:AER). The holdings are mainly concentrated in 9 of all the 11 industries: Utilities, Healthcare, Industrials, Financial Services, Communication Services, Consumer Defensive, Technology, Basic Materials, and Energy. This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein. This article first appeared on GuruFocus.
Yahoo
9 minutes ago
- Yahoo
Air Canada union takes aim at Feds as company seeks binding arbitration
After Canadian Job Minister Patty Hajdu asked the Canadian Union of Public Employees (CUPE) to respond to Air Canada's request for her to send the two parties to binding arbitration, the union representing the airline's flight attendants has responded with frustration.
Yahoo
9 minutes ago
- Yahoo
David Einhorn's Strategic Moves: Fluor Corp Takes Center Stage with 8.42% Portfolio Share
Exploring the Latest 13F Filing of Greenlight Capital David Einhorn (Trades, Portfolio) recently submitted the 13F filing for the second quarter of 2025, providing insights into his investment moves during this period. David Einhorn (Trades, Portfolio) is president of Greenlight Capital, a value-oriented investment advisor founded in 1996. The hedge fund is based in New York. Greenlight invests primarily in publicly traded North American corporate debt offerings and equities. Einhorn believes an investment approach emphasizing intrinsic value will achieve consistent absolute investment returns and safeguard capital regardless of market conditions. He is a noted activist investor, taking positions in companies, and then pushing management to implement changes. Warning! GuruFocus has detected 1 Warning Sign with GRBK. Summary of New Buy David Einhorn (Trades, Portfolio) added a total of 4 stocks, among them: The most significant addition was Fluor Corp (NYSE:FLR), with 3,819,580 shares, accounting for 8.42% of the portfolio and a total value of $195.83 million. The second largest addition to the portfolio was The Cigna Group (NYSE:CI), consisting of 93,750 shares, representing approximately 1.33% of the portfolio, with a total value of $30.99 million. The third largest addition was Victoria's Secret & Co (NYSE:VSCO), with 887,750 shares, accounting for 0.71% of the portfolio and a total value of $16.44 million. Key Position Increases David Einhorn (Trades, Portfolio) also increased stakes in a total of 8 stocks, among them: The most notable increase was Graphic Packaging Holding Co (NYSE:GPK), with an additional 3,658,850 shares, bringing the total to 4,705,950 shares. This adjustment represents a significant 349.43% increase in share count, a 3.31% impact on the current portfolio, with a total value of $99.15 million. The second largest increase was Teva Pharmaceutical Industries Ltd (NYSE:TEVA), with an additional 3,210,577 shares, bringing the total to 3,778,777. This adjustment represents a significant 565.04% increase in share count, with a total value of $63.33 million. Summary of Sold Out David Einhorn (Trades, Portfolio) completely exited 3 of the holdings in the second quarter of 2025, as detailed below: Viatris Inc (NASDAQ:VTRS): David Einhorn (Trades, Portfolio) sold all 6,000,830 shares, resulting in a -2.65% impact on the portfolio. Dollar Tree Inc (NASDAQ:DLTR): David Einhorn (Trades, Portfolio) liquidated all 436,360 shares, causing a -1.66% impact on the portfolio. Key Position Reduces David Einhorn (Trades, Portfolio) also reduced positions in 8 stocks. The most significant changes include: Reduced Peloton Interactive Inc (NASDAQ:PTON) by 4,823,938 shares, resulting in a -96.41% decrease in shares and a -1.54% impact on the portfolio. The stock traded at an average price of $6.49 during the quarter and has returned 30.14% over the past 3 months and -0.98% year-to-date. Reduced Kyndryl Holdings Inc (NYSE:KD) by 823,910 shares, resulting in a -19.92% reduction in shares and a -1.31% impact on the portfolio. The stock traded at an average price of $36.09 during the quarter and has returned -26.85% over the past 3 months and -12.88% year-to-date. Portfolio Overview At the second quarter of 2025, David Einhorn (Trades, Portfolio)'s portfolio included 34 stocks, with top holdings including 25.59% in Green Brick Partners Inc (NYSE:GRBK), 8.42% in Fluor Corp (NYSE:FLR), 6.46% in Core Natural Resources Inc (NYSE:CNR), 6.38% in Brighthouse Financial Inc (NASDAQ:BHF), and 5.97% in Kyndryl Holdings Inc (NYSE:KD). The holdings are mainly concentrated in 8 of all the 11 industries: Consumer Cyclical, Energy, Industrials, Healthcare, Technology, Financial Services, Basic Materials, and Communication Services. This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein. This article first appeared on GuruFocus. Sign in to access your portfolio
